Ypsomed Holding AG (YPHDF)
476.49
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.016B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 1.06% |
| Valuation | |
| PE Ratio | 23.54 |
| PE Ratio (Forward) | |
| PS Ratio | 7.114 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 3.350 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Ypsomed Holding AG engages in the development and manufacture of self-injection systems and drug delivery devices for pharmaceutical and biotechnology companies. It operates through the following segment: Delivery Systems. The Delivery Systems segment consists of pen injectors, autoinjectors, and wearable on-body devices, including UnoPen, ServoPen, YpsoPen, FixPen, YpsoMate, YpsoLoop, YpsoDose, LyoTwist, and VarioJect. The company was founded by Wilhelm Michel on December 29, 2003 and is headquartered in Burgdorf, Switzerland. |
| URL | http://www.ypsomed.com |
| Investor Relations URL | N/A |
| HQ State/Province | Bern (Berne) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 11, 2026 |
| Last Earnings Release | May. 20, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 06, 2026 |
Profile
| Ypsomed Holding AG engages in the development and manufacture of self-injection systems and drug delivery devices for pharmaceutical and biotechnology companies. It operates through the following segment: Delivery Systems. The Delivery Systems segment consists of pen injectors, autoinjectors, and wearable on-body devices, including UnoPen, ServoPen, YpsoPen, FixPen, YpsoMate, YpsoLoop, YpsoDose, LyoTwist, and VarioJect. The company was founded by Wilhelm Michel on December 29, 2003 and is headquartered in Burgdorf, Switzerland. |
| URL | http://www.ypsomed.com |
| Investor Relations URL | N/A |
| HQ State/Province | Bern (Berne) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 11, 2026 |
| Last Earnings Release | May. 20, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 06, 2026 |